Han. “CD109 Is a Potential Biomarker for Malignant Tumors”. American Journal of Translational Medicine 4, no. 3 (November 12, 2020): 111–121. Accessed May 11, 2024. https://journals.publicknowledgeproject.org/default3/index.php/ajtm/article/view/589.